New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Sabra Healthcare REIT, Inc.

SBRA

Real Estate Reit Healthcare Facilities

Sabra Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $774.6 million, up 10.2% from fiscal 2024.

Revenue
+31.3%
EPS
+22.2%
Free cash flow
n/m
Total debt
−5.99%

Quarter to September 2026, against a year earlier

20.39 0.07 −0.34%

After hours trading: 20.39, unchanged, last trade 4:01pm Eastern.

Market cap
$5.4B
P/E
72.8×
Fwd P/E FY26e
62.6×
Dividend yield
5.89%
F-score
5/9
ROIC
1.95%
Net debt / EBITDA
5.5×
Payout ratio
4.3×

Ratios over time FY16 to FY25

Returns on capital

ROIC was 3.04% in FY25, against a low of 1.60% in FY22.

ROEROIC
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
ROE5.8%6.6%8.0%2.0%4.0%−3.3%−2.4%0.5%4.6%5.6%
ROIC3.8%2.0%3.0%2.3%2.8%2.2%1.6%2.5%2.9%3.0%

Debt

Net debt is 5.53× a year’s EBITDA. Debt is 0.90× equity, against 1.19× in FY16.

Debt / equityNet debt / EBITDA
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Debt / equity1.2×1.0×1.0×0.7×0.7×0.7×0.8×0.9×0.9×0.9×
Net debt / EBITDA5.9×9.1×6.4×5.9×5.4×6.0×7.5×6.1×5.8×5.5×

Per share, from FY16

Since FY16, per share: revenue has fallen 2.39% a year; book value has fallen 3.11% a year.

Free cash flowRevenueBook value
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Free cash flow1.0×−0.7×1.4×1.8×0.6×0.8×0.6×0.9×0.5×−0.1×
Revenue1.0×1.0×0.9×0.9×0.7×0.7×0.7×0.7×0.8×0.8×
Book value1.0×2.1×1.2×1.2×1.1×1.0×0.9×0.8×0.8×0.8×
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
5 4 6 5 4 3 4 6 6 5
P/E ratio
26.76 13.70 10.84 62.76 25.93 0.00 0.00 283.80 32.07 29.14
P/S ratio
6.17 4.94 4.71 6.04 5.98 5.21 4.66 5.07 5.75 5.90
P/FCF ratio
13.47 0.00 6.47 6.39 15.49 9.42 11.36 8.53 18.78 0.00
P/Operating CF
38.17 24.43 37.89 41.83 40.07 30.29 43.09 41.67 50.57 52.28
P/B ratio
1.58 0.59 0.90 1.15 1.05 0.88 0.95 1.17 1.48 1.62
EV/Sales
10.68 11.81 9.80 9.59 9.84 9.21 8.59 8.72 9.09 9.06
EV/EBITDA
13.87 15.59 12.31 15.90 13.75 13.79 16.34 14.47 15.67 15.83
EV/FCF
23.32 (34.25) 13.46 10.16 25.46 16.65 20.93 14.68 29.69 (122.74)
Current Ratio
3.30 6.85 1.83 1.44 1.15 3.60 3.27 3.41 4.32 4.29
Net Debt/EBITDA
5.86 9.07 6.39 5.89 5.38 5.99 7.47 6.07 5.76 5.53
Debt/Equity
1.19 0.99 0.99 0.69 0.70 0.71 0.82 0.86 0.88 0.90
ROE
5.80% 6.65% 8.05% 2.05% 4.01% (3.34%) (2.41%) 0.47% 4.57% 5.59%
ROA
2.54% 3.19% 3.93% 1.08% 2.30% (1.90%) (1.32%) 0.25% 2.37% 2.88%
ROIC
3.77% 1.96% 2.97% 2.33% 2.75% 2.22% 1.60% 2.50% 2.93% 3.04%
Return on Tangible Assets
2.86% 2.25% 4.54% 1.28% 2.61% (2.05%) (1.47%) 0.28% 2.58% 3.06%
Earnings Yield
3.74% 7.30% 9.22% 1.59% 3.86% (3.77%) (2.70%) 0.35% 3.12% 3.43%
Free Cash Flow Yield
7.43% (6.98%) 15.45% 15.65% 6.46% 10.62% 8.80% 11.73% 5.33% (1.25%)
Free Cash Flow per Share
1.83 (1.33) 2.55 3.34 1.12 1.44 1.11 1.66 0.92 (0.24)
Book value per Share
15.56 32.54 18.25 18.64 16.53 15.43 13.23 12.12 11.74 11.70
Free Cash Flow
119.35 (140.83) 453.94 624.94 231.30 315.01 256.36 384.81 215.40 (57.20)
EV/EBIT
21.07 24.68 20.04 29.15 23.40 26.06 38.14 27.26 26.81 27.37
Other line items

Show all line items

Columns are period end dates · fundamentals updated Nov 18, 2026